EFG Asset Management (Americas)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,530
| Closed | -$201K | – | 139 |
|
|
2022
Q4 | $201K | Buy |
+1,530
| New | +$201K | 0.05% | 129 |
|
|
2022
Q1 | – | Sell |
-1,525
| Closed | -$233K | – | 137 |
|
|
2021
Q4 | $233K | Buy |
1,525
+1
| +0.1% | +$153 | 0.04% | 131 |
|
|
2021
Q3 | $246K | Buy |
1,524
+1
| +0.1% | +$161 | 0.04% | 135 |
|
|
2021
Q2 | $249K | Hold |
1,523
| – | – | 0.05% | 135 |
|
|
2021
Q1 | $229K | Buy |
1,523
+1
| +0.1% | +$150 | 0.05% | 133 |
|
|
2020
Q4 | $231K | Buy |
1,522
+1
| +0.1% | +$152 | 0.05% | 133 |
|
|
2020
Q3 | $206K | Buy |
1,521
+1
| +0.1% | +$135 | 0.05% | 136 |
|
|
2020
Q2 | $208K | Buy |
+1,520
| New | +$208K | 0.05% | 121 |
|
|
2015
Q1 | – | Sell |
-1,200
| Closed | -$121K | – | 180 |
|
|
2014
Q4 | $121K | Buy |
+1,200
| New | +$121K | 0.07% | 117 |
|